Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC2 receptor

This publication has 28 references indexed in Scilit:

• Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy
  International Journal of Peptide and Protein Research, 2009
• VIP and PACAP: very important in pain?
  Trends in Pharmacological Sciences, 1999
• The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy
  Neuropharmacology, 1999
• Effect of introduction of an Arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
• Vasoactive Intestinal Peptide (VIP)1 Receptor
  Published by Elsevier ,1996
• Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma
  Biopolymers, 1995
• Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal Domains
  Biochemical and Biophysical Research Communications, 1994
• A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists
  Peptides, 1994
• Transmitter Role of Vasoactive Intestinal Peptide
  Basic & Clinical Pharmacology & Toxicology, 1993
• Conformational Analysis of Vasoactive Intestinal Peptide and Related Fragments^a
  Annals of the New York Academy of Sciences, 1988